Gene expression in Barrett's esophagus: Laser capture versus whole tissue

Objective. Diagnosis of Barrett's esophagus (BE) is typically done through morphologic analysis of esophageal tissue biopsy. Such samples contain several cell types. Laser capture microdissection (LCM) allows the isolation of specific cells from heterogeneous cell populations. The purpose of this study was to determine the degree of overlap of the two sample types and to define a set of genes that might serve as biochemical markers for BE. Material and methods. Biopsies were obtained from regions of the glandular tissue of BE and normal esophagus from 9 subjects with BE. Samples from 5 subjects were examined as whole tissue (BE [whole]; E [whole]), and in 4 subjects the glandular epithelium of BE was isolated using LCM (BE [LCM]) and compared with the averaged values (E [LCM]) for both basal cell (B [LCM]) and squamous cell (S [LCM]) epithelium. Results. Gene expression revealed 1797 probe sets between BE [whole] and E [whole] (fold change > 2.0; p<0.001). Most of these genes (74%) were also differentially expressed between BE [LCM] and E [LCM], showing that there was high concordance between the two sampling methods. LCM provided a great deal of additional information (2113 genes) about the alterations in gene expression that may represent the BE phenotype. Conclusions. There are differences in gene expression profiles depending on whether specimens are whole tissue biopsies or LCM dissected. Whole tissue biopsies should prove satisfactory for diagnostic purposes. Because the data from LCM samples delineated many more Barrett's-specific genes, this procedure might provide more information regarding pathogenesis than would whole tissue material.

[1]  H. Aburatani,et al.  Overexpression of MUC13 is associated with intestinal‐type gastric cancer , 2005, Cancer science.

[2]  Paul Marjoram,et al.  A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus , 2004, Oncogene.

[3]  Jeffrey S. Morris,et al.  The transcription factor GATA‐6 is overexpressed in vivo and contributes to silencing 15‐LOX‐1 in vitro in human colon cancer , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  A. Ormsby,et al.  Cytokeratin expression patterns in noncardia, intestinal metaplasia‐associated gastric adenocarcinoma , 2002, Cancer.

[5]  L. Sapinoso,et al.  Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas. , 2005, Neoplasia.

[6]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[7]  R. Bresalier,et al.  Mucins and mucin binding proteins in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[8]  H. El‐Serag,et al.  The Use of Cytokeratin Stain to Distinguish Barrett’s Esophagus from Contiguous Tissues: A Systematic Review , 2007, Digestive Diseases and Sciences.

[9]  P. Ramani,et al.  Impaired mucosal regeneration in neonatal necrotising enterocolitis , 2005, Pediatric Surgery International.

[10]  W. L. Ruzzo,et al.  Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae. , 2002, Neoplasia.

[11]  M. Tzardi,et al.  Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. , 2002, Histology and histopathology.

[12]  C. Shaw,et al.  Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. , 2006, Gastrointestinal endoscopy.

[13]  B. Leggett,et al.  The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. , 2006, Human pathology.

[14]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[15]  P. Heikkilä,et al.  Transcription Factor GATA-6 Is Expressed in Malignant Endoderm of Pediatric Yolk Sac Tumors and in Teratomas , 2003, Pediatric Research.

[16]  D. Shibata,et al.  Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays , 2002, Oncogene.

[17]  P. Chambon,et al.  Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.

[18]  N. Blin,et al.  Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2. , 2000, Biochimica et biophysica acta.

[19]  W. Hoffmann.  Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. , 2005, Cellular and molecular life sciences : CMLS.

[20]  Jing Yin,et al.  Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. , 2002, Cancer research.